Acorn Bioventures

cb Email

Status

ACTIVE

Global HQ

New York, United States

Countries of investment

USA
Canada

Investment stages

Seed

Industries

Pharma
Biotechnology
Medical Devices

About
Acorn Bioventures invests across stages in small cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Their investment flexibility allows them to provide value across the entire spectrum from seed financing to public markets.

Min check size: $100K
Max check size: $2M
Fund size: Unlock
NPS: Unlock

Investment Thesis

They Invest in early to growth stage biotechnology companies, focusing on transformative therapies and innovative healthcare solutions.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Top-tier fund specializing in early-stage life sciences and biotechnology investments. Focused on opportunities in North America and Europe, with a portfolio comprising over 25 deals. Notable for several successful exits, including acquisitions by major pharmaceutical companies. Employs a hands-on, operator-led investment style, emphasizing deep domain expertise and strategic partnerships.